← Back to Clinical Trials
Recruiting NCT05204017

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

Trial Parameters

Condition Amyotrophic Lateral Sclerosis
Sponsor University of Alberta
Study Type OBSERVATIONAL
Phase N/A
Enrollment 150
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-09-12
Completion 2025-12

Brief Summary

CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to collect, store, and analyze vast amounts of multimodal information about ALS. These multimodal datasets and biosamples will be made available for use by researchers or industry across Canada and around the world in accordance with the CAPTURE ALS Data Sharing Policy to advance research on ALS.

Eligibility Criteria

\[PATIENTS\] Inclusion Criteria: 1. Has ALS, classified as definite, probable, laboratory-supported probable, or possible ALS according to the revised El Escorial criteria or a related neurodegenerative disorder including ALS-FTD, PLS, PMA or asymptomatic individuals with a known ALS mutation (as previously confirmed during regular clinical care) 2. Be of the age of majority in their province of residence/treatment 3. Have the cognitive capacity to provide informed consent 4. Have proficiency in English or French in order to understand study instructions and respond to questionnaires Exclusion Criteria: N/A \[HEALTHY CONTROLS\] Inclusion Criteria: 1. Be between the ages of 40-80 unless age matched to a patient (+/-3 years) who is already enrolled 2. Be the age of majority in their province of residence/treatment 3. Have the cognitive capacity to provide informed consent 4. Have proficiency in English of French to understand study instructions and respond to questionnaires Exclusion Cri

Related Trials